Attached files

file filename
EX-4.1 - FORM OF MEDIUM-TERM NOTES, SERIES K, SECURITIES LINKED TO THE RUSSELL 2000 INDEX - WELLS FARGO & COMPANY/MNd506442dex41.htm
EX-4.2 - FORM OF MEDIUM-TERM NOTES, SERIES K, SECURITIES LINKED TO THE RUSSELL 2000 INDEX - WELLS FARGO & COMPANY/MNd506442dex42.htm
EX-5.1 - OPINION OF FAEGRE BAKER DANIELS LLP REGARDING THE NOTES - WELLS FARGO & COMPANY/MNd506442dex51.htm
EX-8.1 - OPINION OF SULLIVAN & CROMWELL LLP REGARDING THE NOTES - WELLS FARGO & COMPANY/MNd506442dex81.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (date of earliest event reported): March 22, 2013

 

 

WELLS FARGO & COMPANY

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-2979   No. 41-0449260
(State or other jurisdiction   (Commission File   (IRS Employer
of incorporation)   Number)   Identification No.)

420 Montgomery Street, San Francisco, California 94104

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: 1-866-249-3302

Not applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

  ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

  ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

  ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

  ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 9.01. Financial Statements and Exhibits

Exhibits are filed herewith in connection with the Registration Statement on Form S-3 (File No. 333-180728) filed by Wells Fargo & Company with the Securities and Exchange Commission.

On March 22, 2013, Wells Fargo & Company issued the following Medium-Term Notes, Series K: Securities Linked to the Russell 2000® Index due March 22, 2019; and Securities Linked to the Russell 2000® Index due March 22, 2019 (collectively, the “Notes”).

The purpose of this Current Report is to file with the Securities and Exchange Commission the form of Note related to each issuance, the opinion of Faegre Baker Daniels LLP regarding the Notes and the opinion of Sullivan & Cromwell LLP, Wells Fargo & Company’s special tax counsel, regarding the Notes.

 

  (d) Exhibits

 

  4.1

Form of Medium-Term Notes, Series K, Securities Linked to the Russell 2000® Index due March 22, 2019.

 

  4.2

Form of Medium-Term Notes, Series K, Securities Linked to the Russell 2000® Index due March 22, 2019.

 

  5.1 Opinion of Faegre Baker Daniels LLP regarding the Notes.

 

  8.1 Opinion of Sullivan & Cromwell LLP regarding the Notes.

 

  23.1 Consent of Faegre Baker Daniels LLP (included as part of Exhibit 5.1).

 

  23.2 Consent of Sullivan & Cromwell LLP (included as part of Exhibit 8.1).

 

2


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

    WELLS FARGO & COMPANY

DATED: March 22, 2013

    /s/ Paul R. Ackerman
    Paul R. Ackerman
    Executive Vice President and Treasurer

 

3


Index to Exhibits

 

Exhibit No.    Description    Method of Filing
4.1    Form of Medium-Term Notes, Series K, Securities Linked to the Russell 2000® Index due March 22, 2019.   

Electronic

Transmission

4.2    Form of Medium-Term Notes, Series K, Securities Linked to the Russell 2000® Index due March 22, 2019.   

Electronic

Transmission

5.1    Opinion of Faegre Baker Daniels LLP regarding the Notes.   

Electronic

Transmission

8.1    Opinion of Sullivan & Cromwell LLP regarding the Notes.   

Electronic

Transmission

23.1    Consent of Faegre Baker Daniels LLP (included as part of Exhibit 5.1).   
23.2    Consent of Sullivan & Cromwell LLP (included as part of Exhibit 8.1).   

 

4